Is a complete XFOR research report available?

No complete published report is available for X4 Pharmaceuticals, Inc. (XFOR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

X4 Pharmaceuticals, Inc. (XFOR)

NASDAQ: XFOR · USD

$3.32

+0.07 (+2.1%)· Recorded snapshot

Market cap	329.2M
Revenue (ttm)	15.8M
Net income (ttm)	-90.1M
EPS (ttm)	-$0.89
Shares out	99.1M
Volume	435,718
Beta	0.46

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 15.8M
Net income (ttm): -90.1M
EPS (ttm): -$0.89
Market cap: 329.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Conserver

Metric	Value
Amount currency	USD
CIK code	0001501697
Company name	X4 Pharmaceuticals, Inc.
Country	United States
Country code	US
CUSIP number	98420X202
Earnings date	2026-11-09
Earnings time	bmo
Employees	45
Employees change	-98
Employees growth	-68.53%
Enterprise value	$198.4M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2014
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US98420X2027
Last 10-K release date	2026-03-17
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2025-04-28
Last stock split type	Reverse
Market cap	$329.2M
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$3.32
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	XFOR
U.S. state	Massachusetts
Website	https://www.x4pharma.com

Metric

Value

Amount currency

USD

CIK code

0001501697

Company name

X4 Pharmaceuticals, Inc.

Country

United States

Country code

CUSIP number

98420X202

Earnings date

2026-11-09

Earnings time

bmo

Employees

Employees change

-98

Employees growth

-68.53%

Enterprise value

$198.4M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2014

In index

RUSSELL2000

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US98420X2027

Last 10-K release date

2026-03-17

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split date

2025-04-28

Last stock split type

Reverse

Market cap

$329.2M

Market cap category

Small-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$3.32

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

XFOR

U.S. state

Massachusetts

Website

https://www.x4pharma.com

Metric	Value
Earnings yield	-26.71%
EV/Sales	12.4x
FCF / EV yield	-42.63%
FCF yield	-25.59%
Forward EV/Sales	20.51x
Forward P/S	34.15x
P/B ratio	2.01x
P/S ratio	20.65x
Price / tangible book value	2.62x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-26.71%

EV/Sales

12.4x

FCF / EV yield

-42.63%

FCF yield

-25.59%

Forward EV/Sales

20.51x

Forward P/S

34.15x

P/B ratio

2.01x

P/S ratio

20.65x

Price / tangible book value

2.62x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Gross margin	81.51%
Operating margin	-509.06%
Pretax margin	-568.98%
Profit per employee	$-2M
Revenue per employee	$352,156
ROA	-28.15%
ROA (5Y)	-41.4%
ROCE	-34.52%
ROE	-113.08%
ROE (5Y)	-120.96%
ROIC	-326.48%
SBC / revenue	53.83%
Tax / revenue	-0.18%

Metric

Value

Gross margin

81.51%

Operating margin

-509.06%

Pretax margin

-568.98%

Profit per employee

$-2M

Revenue per employee

$352,156

ROA

-28.15%

ROA (5Y)

-41.4%

ROCE

-34.52%

ROE

-113.08%

ROE (5Y)

-120.96%

ROIC

-326.48%

SBC / revenue

53.83%

Tax / revenue

-0.18%

Metric	Value
EPS growth quarters	1
EPS growth years	4
Gross profit growth	-52.52%
Gross profit growth (Q)	336.49%
Net income growth quarters	1
Net income growth years	0
Revenue growth	-51.65%
Revenue growth (Q)	346.33%
Revenue growth (QoQ)	225.18%
Revenue growth quarters	1
Revenue growth years	1

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

-52.52%

Gross profit growth (Q)

336.49%

Net income growth quarters

Net income growth years

Revenue growth

-51.65%

Revenue growth (Q)

346.33%

Revenue growth (QoQ)

225.18%

Revenue growth quarters

Revenue growth years

Metric	Value
Depreciation and amortization	$1.7M
EBIT	$-80.7M
EBITDA	$-79M
EPS	$-0.89
FCF per share	$-0.84
Financing cash flow	$233.1M
Free cash flow	$-83.7M
Free cash flow minus SBC	$-92.3M
Gross profit	$12.9M
Income taxes	$-28,000
Investing cash flow	$6.4M
Net cash flow	$155.7M
Net income	$-90.1M
Operating cash flow minus SBC	$-92.3M
Operating income	$-80.7M
Revenue	$15.8M
Stock-based compensation	$8.5M

Metric

Value

Depreciation and amortization

$1.7M

EBIT

$-80.7M

EBITDA

$-79M

EPS

$-0.89

FCF per share

$-0.84

Financing cash flow

$233.1M

Free cash flow

$-83.7M

Free cash flow minus SBC

$-92.3M

Gross profit

$12.9M

Income taxes

$-28,000

Investing cash flow

$6.4M

Net cash flow

$155.7M

Net income

$-90.1M

Operating cash flow minus SBC

$-92.3M

Operating income

$-80.7M

Revenue

$15.8M

Stock-based compensation

$8.5M

Metric	Value
Altman Z-Score	-1.99
Book value per share	$1.62
Debt / equity	0.5
Goodwill	$17.4M
Interest coverage	-9.23
Long-term assets	$34.2M
Long-term liabilities	$78.2M
Net cash (debt)	$130.7M
Net cash / market cap	39.96%
Net debt / equity	-0.84
Piotroski F-Score	2
Property, plant and equipment	$765,000
Shareholders' equity	$155.5M
Tangible book value	$125M
Tangible book value per share	$1.30
Total assets	$253.1M
Total cash	$208M
Total debt	$77.2M
Total liabilities	$97.6M
WACC	7.2%

Metric

Value

Altman Z-Score

-1.99

Book value per share

$1.62

Debt / equity

0.5

Goodwill

$17.4M

Interest coverage

-9.23

Long-term assets

$34.2M

Long-term liabilities

$78.2M

Net cash (debt)

$130.7M

Net cash / market cap

39.96%

Net debt / equity

-0.84

Piotroski F-Score

Property, plant and equipment

$765,000

Shareholders' equity

$155.5M

Tangible book value

$125M

Tangible book value per share

$1.30

Total assets

$253.1M

Total cash

$208M

Total debt

$77.2M

Total liabilities

$97.6M

WACC

7.2%

Metric	Value
Asset turnover	0.09
Current assets	$218.9M
Current liabilities	$19.4M
Current ratio	11.3
Inventory turnover	0.68
Net working capital	$-8M
Quick ratio	10.84
Working capital	$199.5M
Working capital turnover	0.13

Metric

Value

Asset turnover

0.09

Current assets

$218.9M

Current liabilities

$19.4M

Current ratio

11.3

Inventory turnover

0.68

Net working capital

$-8M

Quick ratio

10.84

Working capital

$199.5M

Working capital turnover

0.13

Metric	Value
Buyback yield / dilution	-1,374.07%
Dividend yield	0%
Shareholder yield	-1,374.07%

Metric

Value

Buyback yield / dilution

-1,374.07%

Dividend yield

Shareholder yield

-1,374.07%

Metric	Value
150-day SMA	$3.85
1D price change	2.15%
1M price change	10.3%
1M total return	10.3%
1W price change	10.3%
1W total return	10.3%
1Y price change	-11.23%
1Y return CAGR	-11.24%
1Y total return	-11.23%
20-day SMA	$2.90
200-day SMA	$3.81
3M price change	-15.74%
3M total return	-15.74%
3Y price change	-84.37%
3Y return CAGR	-46.13%
3Y total return	-84.37%
50-day SMA	$3.36
50-day SMA vs 200-day SMA	50under200
52-week high	$4.83
52-week high date	2026-03-10
52-week low	$2.43
52-week low date	2026-10-14
5Y price change	-97.44%
5Y return CAGR	-51.95%
5Y total return	-97.44%
6M price change	-21.14%
6M total return	-21.14%
All-time high	$717.90
All-time high date	2019-03-22
All-time low	$1.35
All-time low date	2025-08-11
Average true range (ATR)	$0.21
Average volume	655.7K
Beta (1Y)	1.69
Beta (2Y)	1.24
Beta (5Y)	0.46
Change from 52-week high	-31.26%
Change from 52-week low	36.63%
Change from all-time high	-99.54%
Change from all-time low	145.93%
Change from open	4.73%
Day's gap	-2.46%
Dollar volume	$1.4M
High price	$3.35
Low price	$3.17
Monthly RSI	35.65
Open price	$3.17
Position in 52-week range	83.33%
Premarket change	0.92%
Premarket close	$3.25
Premarket price	$3.28
Previous close	$3.25
Price vs 150-day SMA	-13.65%
Price vs 20-day SMA	14.52%
Price vs 200-day SMA	-12.75%
Price vs 50-day SMA	-1.07%
Relative volume	0.67
RSI	59.63
Sharpe ratio	0.14
Sharpe ratio (3Y)	0.01
Sharpe ratio (5Y)	-0.12
Sortino ratio	0.3
Sortino ratio (3Y)	0.07
Sortino ratio (5Y)	-0.14
Volume	435.7K
Weekly RSI	45.58
YTD price change	-17%
YTD total return	-17%

Metric

Value

150-day SMA

$3.85

1D price change

2.15%

1M price change

10.3%

1M total return

10.3%

1W price change

10.3%

1W total return

10.3%

1Y price change

-11.23%

1Y return CAGR

-11.24%

1Y total return

-11.23%

20-day SMA

$2.90

200-day SMA

$3.81

3M price change

-15.74%

3M total return

-15.74%

3Y price change

-84.37%

3Y return CAGR

-46.13%

3Y total return

-84.37%

50-day SMA

$3.36

50-day SMA vs 200-day SMA

50under200

52-week high

$4.83

52-week high date

2026-03-10

52-week low

$2.43

52-week low date

2026-10-14

5Y price change

-97.44%

5Y return CAGR

-51.95%

5Y total return

-97.44%

6M price change

-21.14%

6M total return

-21.14%

All-time high

$717.90

All-time high date

2019-03-22

All-time low

$1.35

All-time low date

2025-08-11

Average true range (ATR)

$0.21

Average volume

655.7K

Beta (1Y)

1.69

Beta (2Y)

1.24

Beta (5Y)

0.46

Change from 52-week high

-31.26%

Change from 52-week low

36.63%

Change from all-time high

-99.54%

Change from all-time low

145.93%

Change from open

4.73%

Day's gap

-2.46%

Dollar volume

$1.4M

High price

$3.35

Low price

$3.17

Monthly RSI

35.65

Open price

$3.17

Position in 52-week range

83.33%

Premarket change

0.92%

Premarket close

$3.25

Premarket price

$3.28

Previous close

$3.25

Price vs 150-day SMA

-13.65%

Price vs 20-day SMA

14.52%

Price vs 200-day SMA

-12.75%

Price vs 50-day SMA

-1.07%

Relative volume

0.67

RSI

59.63

Sharpe ratio

0.14

Sharpe ratio (3Y)

0.01

Sharpe ratio (5Y)

-0.12

Sortino ratio

0.3

Sortino ratio (3Y)

0.07

Sortino ratio (5Y)

-0.14

Volume

435.7K

Weekly RSI

45.58

YTD price change

-17%

YTD total return

-17%

Metric	Value
Float	57.2M
Float percentage	57.71%
Shares change (QoQ)	0.04%
Shares change (YoY)	1,374.07%
Shares held by insiders	0.69%
Shares held by institutions	62.03%
Shares outstanding	99.1M
Short % of float	13.09%
Short % of shares	7.56%
Short ratio	6.4 days

Metric

Value

Float

57.2M

Float percentage

57.71%

Shares change (QoQ)

0.04%

Shares change (YoY)

1,374.07%

Shares held by insiders

0.69%

Shares held by institutions

62.03%

Shares outstanding

99.1M

Short % of float

13.09%

Short % of shares

7.56%

Short ratio

6.4 days

X4 Pharmaceuticals, Inc. (XFOR)

Price

Financial snapshot

Fair-value bridge

Latest news · XFOR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All XFOR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on XFOR

Frequently asked questions